A clinical research consulting firm that specializes in the execution of early phase trials. ARS, Inc., has significant experience in Oncology, Infectious Disease, Pediatrics and formualtion development.

The Maine Vaccine Board (MVB) was formed by the state legislature in 2010 to help the state to reinstate its universal purchase of vaccines for children under age 19. The MVB administers the flow of vaccine funds by collecting payments from health plans, insurance companies, and other payers and remitting the funds to the state. Through the Maine CDC's Childhood Vaccine Program, the state purchases vaccines at favorable rates and distributes them to providers at no charge.Mr. Connor serves as the representative for vaccine manufacturers. He was unanimously elected as Board Chair in September 2023.

Embera NeuroTherapeutics, Inc. is a specialty pharmaceutical company focused on developing treatments for smoking cessation, cocaine dependence and other addictions, for which there are a limited range of effective drug therapies or no approved treatments. Embera is developing an innovative drug combination (EMB-001) targeting the stress response system and specific brain functions that lead to craving and relapse associated with these disorders.Mr. Connor heads up Embera’s clinical operations, and is leading Embera's Phase 2 POC studies in Cocaine Use Disorder and Tobacco Use Disorder. He has more than 20 years of healthcare experience, with the past 18 years dedicated to clinical operations/project management including: study design, managing budgets and timelines, selection and management of CRO’s, managing staff, developing and implementing patient recruitment strategies, writing SOP’s, CRF Completion Guidelines and other study related documents, and assuring GCP compliance.

The Bioscience Association of Maine (BAM) is a trade organization which promotes the industry's steady growth, interprets its benefits to the public, and influences pertinent public policy.Mr. Connor served as the Co-Chair of the Advocacy Committee

The National Children’s Study will examine the effects of the environment, as broadly defined to include factors such as air, water, diet, sound, family dynamics, community and cultural influences, and genetics on the growth, development, and health of children across the United States, following them from before birth until age 21 years. The goal of the Study is to improve the health and well-being of children and contribute to understanding the role various factors have on health and disease.As nurse manager, Mr. Connor oversees the department and laboratory responsible for the collection and processing of biological and environmental samples.

Represent House District 140.http://www.garyconnor.orgAmerican Academy of Pediatrics, Maine Chapter: Legislator of the Year -2008Maine Primary Care Association: Legislator of the Year -2009Maine Center for Disease Control and Prevention: The Pump-Handle Award 2010 (for outstanding contributionto the reporting, monitoring, prevention, and control of communicable diseases.)

Registered Nurse, First Assistant to the Chief of Pediatric Surgery